A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyRecent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelImmunomodulation of nanoparticles in nanomedicine applicationsHonokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosisFolate/NIR 797-conjugated albumin magnetic nanospheres: synthesis, characterisation, and in vitro and in vivo targeting evaluation.Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine.Plasmonic fluorescent CdSe/Cu2S hybrid nanocrystals for multichannel imaging and cancer directed photo-thermal therapy.Biotargeted nanomedicines for cancer: six tenets before you beginTargeted polymeric therapeutic nanoparticles: design, development and clinical translationQuercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors.Treating metastatic cancer with nanotechnology.Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Nanopharmaceuticals to target antifilarials: a comprehensive review.Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences.The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.A target-triggered exponential amplification-based DNAzyme biosensor for ultrasensitive detection of folate receptors.Folate-mediated chemotherapy and diagnostics: An updated review and outlook.Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells.Direct observation of key photoinduced dynamics in a potential nano-delivery vehicle of cancer drugs.Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors.Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.Alginate-based microcapsules with a molecule recognition linker and photosensitizer for the combined cancer treatment.Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics.Conjugated polymer and gold nanoparticle co-loaded PLGA nanocomposites with eccentric internal nanostructure for dual-modal targeted cellular imaging.In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.Enhanced In Vivo Tumor Detection by Active Tumor Cell Targeting Using Multiple Tumor Receptor-Binding Peptides Presented on Genetically Engineered Human Ferritin Nanoparticles.Global financial challenge: opportunities for strengthening R&D research in targeted drug delivery.Biomimetic strategies for targeted nanoparticle delivery.A dual-targeting nanocarrier based on modified chitosan micelles for tumor imaging and therapyHydrogel-Based Controlled Release Formulations: Designing Considerations, Characterization Techniques and Applications
P2860
Q26745710-B67BDD3C-794D-452A-9182-926AFB05A035Q27010654-58AED15C-6091-44CA-9A23-1AC62C04D6C7Q27021145-37B83E16-0333-408E-A74D-41340B9863C4Q28540108-7B78457D-8528-4299-A56F-B968F200581EQ34133934-436289DA-D7AA-48C7-8898-9C254815A633Q34171019-7E5110D9-2035-424D-8118-4C85BC4B416AQ35846387-70A23847-AFC8-43DD-840D-B7350B2015E4Q36814280-8A1A1608-1A54-45A3-90C4-78CA471CEA0AQ36934007-7FAB384B-1BA7-4149-B34B-6A8AC2EE7C5DQ37362640-8266B0AC-4B32-4B40-9D46-9764788528DFQ37525035-452C9DE0-83D0-4FCE-B1D4-60EF2C6001C8Q37970910-7BB0FE35-9648-4451-9E01-76865DA7C453Q38055067-D0791BE1-15BC-4A06-BA8A-ACB0D65D7A67Q38067265-0FFC8619-8586-4D8B-9CE3-7A4D4A161F3CQ38083301-8A60A2FE-2C5A-42B1-9D3E-F59FCEB540A8Q38134133-913B68A6-2BA7-4022-AADE-D35CF6FE1433Q38809044-4E3C0427-30C8-4BAF-8DA6-1DD64652F2D6Q38944574-A7D16401-B10A-459C-8002-99F88FB90649Q39149880-C6A65018-1FF8-46A3-A1BD-1CB0A9DE4229Q39289664-9328C6FB-F48F-405F-821F-B28CF3027A97Q41675855-EFFCD18A-21C6-4151-B551-FB569ABD8EBBQ43724449-8F42EF68-B139-4E4B-BEA3-5FC7205A6DC7Q45057675-83869D64-D6F8-4DF5-8FD1-FAF927FFDD18Q45348934-11D1FC45-87FA-4E56-9332-75A429DB18BFQ47119535-79C9FBAA-EB83-48F1-AA6F-D5D9BEC87004Q50511998-7510512C-1DF7-429E-A598-6B4CAC7BDF0AQ50914810-CD36B611-2B12-4A4B-AB23-344C797D9E4CQ51274913-EE42F0B6-4E4A-4C19-AAEB-33F622FFE90AQ51650648-4CC98959-5ADB-453C-8679-CDE3DD57DD4DQ55209384-89DC2260-42C0-4638-A457-162CE66AE984Q57273266-87607BF7-1C03-4EFB-8334-CC720DBCFEBEQ57378159-68A35BAC-B69B-49D2-A981-6429B6E36222
P2860
A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A folate receptor-targeting na ...... tance in a human cancer model.
@en
A folate receptor-targeting na ...... tance in a human cancer model.
@nl
type
label
A folate receptor-targeting na ...... tance in a human cancer model.
@en
A folate receptor-targeting na ...... tance in a human cancer model.
@nl
prefLabel
A folate receptor-targeting na ...... tance in a human cancer model.
@en
A folate receptor-targeting na ...... tance in a human cancer model.
@nl
P2093
P2860
P356
P1433
P1476
A folate receptor-targeting na ...... stance in a human cancer model
@en
P2093
Ada Gjyrezi
Dong M Shin
Edwin H Shin
Lydia Koenig
Mourad Tighiouart
Shuming Nie
Yuxiang Wang
Zhuo Georgia Chen
P2860
P304
P356
10.1021/NN200739Q
P407
P577
2011-07-11T00:00:00Z